Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
mAb Beta-56 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb 253 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 6 0
mAb 58 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 6 0
mAb Beta-55 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb 222 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 7 0
mAb Beta-29 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-40 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-47 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-53 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
mAb Beta-54 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0
Excel (.xslx) CSV (.csv)